[1]
2024. The clinical efficacy of integrating dolutegravir into the conventional therapeutic regimen for HIV management. International Journal of Pharmaceutical Sciences and Drug Research. 16, 6 (Nov. 2024), 940–948. DOI:https://doi.org/10.25004/IJPSDR.2024.160603.